BiomX Secures $45M Option for Laser-Radar Counter-Drone System Acquisition

BiomX (NYSE: PHGE) has advanced its strategic pivot into the defense sector by securing an option to acquire control of an Israeli laser-radar counter-drone system. The transaction is valued at approximately $45 million upon closing, marking a significant operational step in the company's new direction. This platform boasts a 99% accuracy rate in real-world deployments across defense and critical infrastructure sectors. To oversee this expansion, the company recently appointed Dr. Ehud Levi, a former Deputy Director of the Mossad, to its Advisory Board. This move transitions BiomX from its traditional biotechnology roots toward the high-growth market of aerial security and defense technology. Investors are closely monitoring the integration of this high-precision technology as the company seeks to capture opportunities in global security markets.